Skip to main content
Caplight Logo









Westlake Therapeutics

Westlake Therapeutics

Private
HangzhouHealthcare & Life Scienceshttps://westlaketpx.com/

Last Round

Series B

Jun 18, 2026

Total Funding Raised

$74.48M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Westlake Therapeutics is a biotechnology company that develops engineered red blood cell therapies for the treatment of cancer, autoimmune diseases, and metabolic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

red blood cell therapyRBC therapeuticscell therapycellular medicinedrug delivery platformerythrocyte drug conjugateEDCtargeted therapybiotechnologyimmune modulationbiomanufacturingcell engineeringoncology therapeuticsmRNA deliverynext-gen biologics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Westlake Therapeutics Comparables

Compare Westlake Therapeutics with similar companies based on industry and business-model similarity.

Westlake Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Coastar Therapeutics
83%
Synth-Med Biotechnology Inc.
83%
Scarlet Therapeutics
78%

Westlake Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 18, 2026
Series A ExtensionJun 25, 2022
Series AJul 15, 2021
Pre SeedJan 25, 2021
Pre SeedJun 2, 2020

Westlake Therapeutics Investors

Notable investors and investment history

Westlake Therapeutics investors
InvestorRounds
Tasly Holding GroupPre Seed
Eight Roads VenturesPre Seed, Series A
西湖科创投Series A Extension, Pre Seed
Shaanxi Investment GroupPre Seed
Westlake District's Science and Technology Direct Investment FundPre Seed
HongShan Capital Group (HSG)Series B, Pre Seed, Series A
Shenzhen Yifeng Investment Management EnterpriseSeries B, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    $15M round led by HongShan Capital Group.

  • Jul 15, 2021

    $15.4M round led by HongShan Capital Group.

Westlake Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Westlake Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Westlake Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range4
Year Founded2020
Last FundingJun 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.